Corrigendum to "Blockage of p38MAPK in astrocytes alleviates brain damage in a mouse model of embolic stroke through the CX43/AQP4 axis" [J Stroke Cerebrovasc Dis. 2024 Dec;33(12):108085/Article Number: YJSCD_JSCVD-D-24-00861].
Weiping Chen, Zhiping Wu, Min Yin, Yangbo Zhang, Yiren Qin, Xu Liu, Jianglong Tu
{"title":"Corrigendum to \"Blockage of p38MAPK in astrocytes alleviates brain damage in a mouse model of embolic stroke through the CX43/AQP4 axis\" [J Stroke Cerebrovasc Dis. 2024 Dec;33(12):108085/Article Number: YJSCD_JSCVD-D-24-00861].","authors":"Weiping Chen, Zhiping Wu, Min Yin, Yangbo Zhang, Yiren Qin, Xu Liu, Jianglong Tu","doi":"10.1016/j.jstrokecerebrovasdis.2025.108229","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":" ","pages":"108229"},"PeriodicalIF":2.0000,"publicationDate":"2025-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Stroke & Cerebrovascular Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jstrokecerebrovasdis.2025.108229","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
期刊介绍:
The Journal of Stroke & Cerebrovascular Diseases publishes original papers on basic and clinical science related to the fields of stroke and cerebrovascular diseases. The Journal also features review articles, controversies, methods and technical notes, selected case reports and other original articles of special nature. Its editorial mission is to focus on prevention and repair of cerebrovascular disease. Clinical papers emphasize medical and surgical aspects of stroke, clinical trials and design, epidemiology, stroke care delivery systems and outcomes, imaging sciences and rehabilitation of stroke. The Journal will be of special interest to specialists involved in caring for patients with cerebrovascular disease, including neurologists, neurosurgeons and cardiologists.